Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

Tytuł pozycji:

IQ driving QI: the Asia Pacific Consortium on Osteoporosis (APCO): an innovative and collaborative initiative to improve osteoporosis care in the Asia Pacific.

Tytuł:
IQ driving QI: the Asia Pacific Consortium on Osteoporosis (APCO): an innovative and collaborative initiative to improve osteoporosis care in the Asia Pacific.
Autorzy:
Chandran M; Osteoporosis and Bone Metabolism Unit, Department of Endocrinology, Singapore General Hospital, 20 College Road, Singapore, 169856, Singapore. .
Bhadada SK; Postgraduate Institute of Medical Education and Research (PGIMER), Chandigarh, India.
Ebeling PR; Department of Medicine, School of Clinical Sciences, Monash University, Melbourne, Australia.
Gilchrist NL; Canterbury District Health Board, Christchurch, New Zealand.
Khan AH; Aga Khan University, Karachi, Pakistan.
Halbout P; International Osteoporosis Foundation, Nyon, Switzerland.
Lekamwasam S; University of Ruhuna, Matara, Sri Lanka.
Lyubomirsky G; Osteoporosis Australia, Sydney, Australia.
Mitchell PJ; Synthesis Medical NZ Limited, Auckland, New Zealand.
Nguyen TV; The Garvan Institute of Medical Research, Sydney, Australia.; University of Technology, Sydney, Australia.
Tiu KL; Queen Elizabeth Hospital, Hong Kong, Hong Kong SAR.
Corporate Authors:
Asia Pacific Consortium on Osteoporosis
Źródło:
Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA [Osteoporos Int] 2020 Nov; Vol. 31 (11), pp. 2077-2081. Date of Electronic Publication: 2020 Jun 19.
Typ publikacji:
Journal Article
Język:
English
Imprint Name(s):
Original Publication: London, UK : Springer International, c1990-
MeSH Terms:
Delivery of Health Care*
Hip Fractures*/epidemiology
Hip Fractures*/etiology
Hip Fractures*/prevention & control
Osteoporosis*/diagnosis
Osteoporosis*/epidemiology
Osteoporosis*/therapy
Asia/epidemiology ; Benchmarking ; Humans
References:
Osteoporos Sarcopenia. 2017 Dec;3(4):161-163. (PMID: 30775524)
Osteoporos Sarcopenia. 2018 Mar;4(1):16-21. (PMID: 30775536)
Osteoporos Int. 2020 Jul;31(7):1193-1204. (PMID: 32266437)
Osteoporos Int. 2015 Sep;26(9):2243-8. (PMID: 26018089)
Osteoporos Int. 2015 Nov;26(11):2573-8. (PMID: 26070301)
Osteoporos Int. 2020 May;31(5):805-826. (PMID: 31788717)
Aging Clin Exp Res. 2019 Jan;31(1):15-17. (PMID: 30612282)
Osteoporos Int. 2017 Jul;28(7):2035-2044. (PMID: 28314898)
Aust Health Rev. 2009 Aug;33(3):423-33. (PMID: 20128758)
Osteoporos Int. 2013 Feb;24(2):393-406. (PMID: 22829395)
Contributed Indexing:
Keywords: Asia Pacific; Clinical standards; Collaboration; Fragility fracture; Osteoporosis; Quality improvement
Entry Date(s):
Date Created: 20200621 Date Completed: 20210217 Latest Revision: 20210217
Update Code:
20240105
PubMed Central ID:
PMC7560927
DOI:
10.1007/s00198-020-05495-w
PMID:
32561953
Czasopismo naukowe
Asia Pacific Consortium on Osteoporosis (APCO) comprises of clinical experts from across the Asia Pacific region, uniting to develop solutions to problems facing osteoporosis management and care. The vision of APCO is to reduce the burden of osteoporosis and fragility fractures in the Asia Pacific region.
Introduction: The Asia Pacific (AP) region comprises 71 countries with vastly different healthcare systems. It is predicted that by 2050, more than half the world's hip fractures will occur in this region. The Asia Pacific Consortium on Osteoporosis (APCO) was set up in May 2019 with the vision of reducing the burden of osteoporosis and fragility fractures in the AP region.
Methods: APCO has so far brought together 39 clinical experts from countries and regions across the AP to develop solutions to challenges facing osteoporosis management and fracture prevention in this highly populous region of the world. APCO aims to achieve its vision by engaging with relevant stakeholders including healthcare providers, policy makers and the public. The initial APCO project is to develop and implement a Framework of pan-AP minimum clinical standards for the screening, diagnosis and management of osteoporosis.
Results and Conclusions: The Framework will serve as a platform upon which new national clinical guidelines can be developed or existing guidelines be revised, in a standardised fashion. The Framework will also facilitate benchmarking for provision of quality of care. It is hoped that the principles underlying the formation and functioning of APCO can be adopted by other regions and that every health care facility and progressively every country in the world can follow our aspirational path and progress towards best practice.

Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies